Literature DB >> 10335859

The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a.

K A Harris1, C Gilham, P P Mortimer, C G Teo.   

Abstract

Hepatitis C virus (HCV) genotypes were assigned to 567 individuals by restriction fragment length polymorphism analysis of the 5' noncoding region of the HCV genome following reverse transcription-polymerase chain reaction. The groups of individuals in this study included hemophilia patients, injecting drug users (IDUs), blood donors, antenatal patients, those attending genitourinary medicine (GUM) clinics, and patients with chronic liver disease, all from England and Wales. The majority of HCV infections were types 1a (32%), 1b (15%), or 3a (37%). The genotype distribution in individual groups was similar to the overall genotype distribution except for hemophilia patients, in whom the frequencies were 1a (39%), 1b (23%), and 3a (21%). With the exception of hemophilia patients, subpopulations in England and Wales appear to share common modes of HCV transmission. There is a need for continued surveillance to monitor the spread of possibly more virulent or drug-resistant HCV genotypes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335859     DOI: 10.1002/(sici)1096-9071(199906)58:2<127::aid-jmv5>3.0.co;2-k

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.

Authors:  C Matheï; E Wollants; J Verbeeck; M Van Ranst; G Robaeys; P Van Damme; F Buntinx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

2.  Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes.

Authors:  Andrew J Buckton; Siew-Lin Ngui; Catherine Arnold; Katie Boast; Joanne Kovacs; Paul E Klapper; Bharat Patel; Imad Ibrahim; Savita Rangarajan; Mary E Ramsay; Chong-Gee Teo
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  The epidemiology of hepatitis C in a UK health regional population of 5.12 million.

Authors:  A H Mohsen
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

4.  Active surveillance of hepatitis C infection in the UK and Ireland.

Authors:  D M Gibb; P E Neave; P A Tookey; M Ramsay; H Harris; K Balogun; D Goldberg; G Mieli-Vergani; D Kelly
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

5.  Hepatitis C viral clearance in an intravenous drug-using cohort in the Dublin area.

Authors:  S Keating; S Coughlan; J Connell; B Sweeney; E Keenan
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

6.  Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study.

Authors:  M Raptopoulou; G Touloumi; D Tzourmakliotis; G Nikolopoulou; M Dimopoulou; G Giannoulis; T Vasiliadis; A Skoutelis; O Anagnostou; G Hatzis; S Manolakopoulos
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

Review 7.  Perinatal hepatitis C virus infection: diagnosis and management.

Authors:  S M Davison; G Mieli-Vergani; J Sira; D A Kelly
Journal:  Arch Dis Child       Date:  2006-09       Impact factor: 3.791

8.  Dynamic coinfection with multiple viral subtypes in acute hepatitis C.

Authors:  Jennifer A Smith; Judith H Aberle; Vicki M Fleming; Peter Ferenci; Emma C Thomson; Peter Karayiannis; Angela R McLean; Heidemarie Holzmann; Paul Klenerman
Journal:  J Infect Dis       Date:  2010-11-10       Impact factor: 5.226

9.  Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.

Authors:  S D Ryder; W L Irving; D A Jones; K R Neal; J C Underwood
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

10.  A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection.

Authors:  M A Balogun; M E Ramsay; J V Parry; L Donovan; N J Andrews; J A Newham; C McGarrigle; K A Harris; C G Teo
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.